×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Metastatic Breast Cancer

Barbara Tako
When roles change over time, use your cancer super powers to help, says melanoma and breast cancer survivor Barbara Tako.
Kristie L. Kahl
In this episode, we’ll talk with founder Donna Deegan herself about the foundation and its efforts, as well as the foundation’s executive director Amanda Napolitano on how much they have raised so far, and we’ll hear from one very inspiring participant Hollis Youngner.
Martha Carlson
There are ways to bring a sense of belonging back to your world.
Katie Kosko
Findings from a new study presented at the American College of Cardiology’s 67th Annual Scientific Session showed that adding two popular heart medications to the chemotherapy regimen may prevent heart damage from happening in these patients.
Barbara Tako
This survivor regrets not being there when her mother passed away from metastatic breast cancer.
Barbara Tako
Breast cancer survivor's questions about genetic testing are ahead of the research.
Kristie L. Kahl
The agency determined the Personal Genome Service Genetic Health Risk (GHR) Report is accurate and can provide reproducible results.
Kristie L. Kahl
The DONNA Foundation hosted its 11th annual marathon weekend in support of research and providing financial assistance to women with breast cancer.
Martha Carlson
How we think about things can have a powerful impact on our experiences. Here's why that matters for people with cancer.
Jason M. Broderick
The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable